DREAM OCT is able to cover an ultrawide field single scan which delivers a 130° OCTA image. DREAM OCT™ swept-source 12 mm super-depth scanning allows superior imaging of the choroid and retina, and a ...

The EIC Soft-landing Programme provides business development support and opportunities to connect with investors, academic institutions and life science stakeholders in Boston – a global hub for ...

Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological ...

When high-performing executives face substance use disorders or mental health challenges, the stakes extend beyond personal well-being to encompass professional legacies, organizational ...

"Liquid biopsy is a revolutionary, non-invasive method for detecting diseases like cancer through blood samples instead of traditional tissue biopsies. This market is rapidly growing, offering ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

When high-performing executives face substance use disorders or mental health challenges, the stakes extend beyond personal well-being to encompass professional legacies, organizational ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

"Liquid biopsy is a revolutionary, non-invasive method for detecting diseases like cancer through blood samples instead of traditional tissue biopsies. This market is rapidly growing, offering ...

Abbreviated breast MRI shortens exam time while retaining a high level of diagnostic accuracy of breast cancer in women with extremely dense breasts, according to an article published today in ...

GC Biopharma, a South Korean pharmaceutical company, announced that its U.S. subsidiary, ABO Holdings, has received FDA approval for its plasma collection center located in Calexico, California.